First Reported Cases Of Schnitzler Syndrome Successfully Treated With Canakinumab (anti-IL-1-beta)

被引：1
|
作者：
Fox, R. [1 ]
Pesek, R. D. [1 ]
机构：
[1] Univ S Florida, Tampa, FL USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2010.12.904
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB227 / AB227
页数：1
相关论文
共 45 条
  • [1] A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumab
    Yuya Fujita
    Tomoyuki Asano
    Akira Sakai
    Natsumi Norikawa
    Toshiyuki Yamamoto
    Haruki Matsumoto
    Shuzo Sato
    Jumpei Temmoku
    Makiko Yashiro-Furuya
    Naoki Matsuoka
    Hiroshi Watanabe
    Kiyoshi Migita
    BMC Musculoskeletal Disorders, 22
  • [2] A case of Schnitzler's syndrome without monoclonal gammopathy successfully treated with canakinumab
    Fujita, Yuya
    Asano, Tomoyuki
    Sakai, Akira
    Norikawa, Natsumi
    Yamamoto, Toshiyuki
    Matsumoto, Haruki
    Sato, Shuzo
    Temmoku, Jumpei
    Yashiro-Furuya, Makiko
    Matsuoka, Naoki
    Watanabe, Hiroshi
    Migita, Kiyoshi
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [3] Efficacy and safety of the anti-interleukin-1 beta antibody canakinumab in patients with Schnitzler's syndrome
    de Koning, H.
    Schalkwijk, J.
    van der Ven-Jongekrijg, J.
    Stoffels, M.
    van der Meer, J.
    Simon, A.
    ALLERGY, 2012, 67 : 106 - 106
  • [4] EFFICACY, SAFETY AND PHARMACOKINETICS OF THE ANTI-INTERLEUKIN-1 BETA ANTIBODY CANAKINUMAB IN PATIENTS WITH SCHNITZLER SYNDROME
    De Koning, H. D.
    Schalkwijk, J.
    van der Ven-Jongekrijg, J.
    Stoffels, M.
    van der Meer, J. W.
    Simon, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 283 - 283
  • [5] Interleukin-1 Beta It Is: High Efficacy of Canakinumab In Schnitzler Syndrome.
    de Koning, Heleen D.
    Schalkwijk, Joost
    van der Ven-Jongekrijg, Johanna
    Stoffels, Monique
    van der Meer, Jos W. M.
    Simon, Anna
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S952 - S953
  • [6] Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
    de Koning, Heleen D.
    Schalkwijk, Joost
    van der Meer, Jos W. M.
    Simon, Anna
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (06) : 1352 - 1354
  • [7] Effectiveness of anti-IL1 in Schnitzler's syndrome
    Klemmer, Nathalie
    Lenain, Pascal
    Balguene, Xavier
    Loet, Xavier
    JOINT BONE SPINE, 2007, 74 (05) : 509 - 510
  • [8] Hemophagocytic Lymphohistiocytosis (HLH) in Noonan's Syndrome (NS) Successfully Treated with Anti-IL-1beta Therapy
    Geng, Bob
    Garcia-Lloret, Maria
    McCurdy, Deborah
    Yen, Eric
    Moss, Tanesha
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB14 - AB14
  • [9] First reported cases of actinic folliculitis treated successfully with topical retinoid
    Rahman, S.
    Powell, J.
    Al-Ismail, D.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (06) : 716 - 718
  • [10] Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome
    de Koning, Heleen D.
    Schalkwijk, Joost
    van der Ven-Jongekrijg, Johanna
    Stoffels, Monique
    van der Meer, Jos W. M.
    Simon, Anna
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (10) : 1634 - 1638
12345